News

Global Alternative Non-Nicotine Liquid Vaping Products Market – Emerging Trends Include Vaping Essential Oils and Vitamins – ResearchAndMarkets.com

April 28, 2020

DUBLIN–(BUSINESS WIRE)–The “Alternative Non-Nicotine Liquid Vaping Products: Complete Market Analysis of Herbals, Extracts and Vitamin Vaping” report has been added to ResearchAndMarkets.com’s offering. This report provides an overview of alternative vaping products without nicotine. It focuses on emerging trends such as vaping essential oils and vitamins, which are taking vaping in a more positive holistic…

Details

Hempyre Holdings Ltd. Launches Global Platform for Branded Hemp-Formulated Consumer Packaged Goods

April 28, 2020

LONDON–(BUSINESS WIRE)–Hempyre Holdings Ltd. (“Hempyre” or the “Company”) is pleased to announce the launch of a global distribution platform of branded hemp-formulated consumer packaged goods focused on beauty, beverage, and wellness. Headquartered in London, Hempyre has agreed to acquire CMLM Holdings, Inc., dba QIND, a U.S.-based provider of hemp-formulated wellness and beauty products featuring CBD…

Details

Halo Announces Extension of the Binding LOI with Canmart Limited And Provides Update on Positive UK Market Developments

April 27, 2020

TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today announces that further to the press releases dated December 24, 2019 and March 3, 2020, the Company has agreed to a second extension of the binding letter of intent (the “LOI”) to acquire all of the common shares of Canmart…

Details

Halo Labs Completes Issuance of Shares to Independent Consultants and Supplier

April 27, 2020

TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today announced the issuance of 10,860,213 common shares of the Company to certain independent consultants of the Company and a supplier of the Company, in lieu of cash consideration (the “Compensation Shares”) at a price of C$0.115 per Compensation Share, being…

Details

UFCW 8-Golden State Members Overwhelmingly Ratify Model Agreements with Raley’s, Bel Air and Nob Hill

April 27, 2020

ROSEVILLE, Calif.–(BUSINESS WIRE)–Following a complex collective bargaining environment, during one of the most challenging periods in the history of the retail industry, members of UFCW 8-Golden State voted overwhelmingly to ratify new agreements with the Raley’s, Bel Air and Nob Hill supermarket chains. “Our members appreciate the value and security this contract provides, which would…

Details

Cresco Labs Announces Record Fourth Quarter & Full Year 2019 Results With Revenue Growth of 144% Year-over-Year and 14% Quarter-Over-Quarter and Pre-Announces First Quarter 2020 Revenue

April 27, 2020

CHICAGO–(BUSINESS WIRE)–Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco” or the “Company”) one of the largest vertically integrated multistate cannabis operators in the United States, today released its unaudited financial results for the fourth quarter ending December 31, 2019. All financial information presented in this release is in U.S. dollars, unless otherwise noted.…

Details

Cresco Labs Announces Mutual Agreement to Terminate Purchase Agreement With Tryke – Frees-Up $55 Million in Capital to Further Invest in Organic Growth Pipeline

April 27, 2020

CHICAGO–(BUSINESS WIRE)–Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it has reached a mutual agreement to terminate the purchase agreement dated September 16, 2019, to acquire certain assets (the “Agreement”) from Tryke Companies, LLC (“Tryke”). Cresco Labs CEO and…

Details

ITHUF INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies iAnthus Capital Holdings, Inc. Shareholders With Losses Exceeding $100K of Class Action and Encourages Investors to Contact the Firm

April 27, 2020

NEW YORK–(BUSINESS WIRE)–Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against iAnthus Capital Holdings, Inc. (“iAnthus” or “the Company”) (OTCMKT: ITHUF) on behalf of shareholders who purchased iAnthus securities between May 14, 2018 and April 6, 2020, inclusive (the ”Class Period”). Such investors are encouraged to join this…

Details

Veriheal Is Now Offering $10,000 in Scholarships to Further Cannabis Innovation

April 27, 2020

DENVER–(BUSINESS WIRE)–Many are eager to learn about cannabis. But the rate of available information is not keeping up with the public’s surging demand. As time presses on, more programs committed to learning about cannabis are becoming available. These classes explore concentrations such as pharmacology, botany, and business where those interested are able to specialize. The…

Details

 Haplotech Inc. wins NRGene’s Cannabis QuickGENETICS™ Contest

April 27, 2020

NESS ZIONA, Israel & SAN DIEGO–(BUSINESS WIRE)–NRGene is pleased to announce that the Canadian company Haplotech Inc. won the international QuickGENETICS™ contest, which was announced in January. Haplotech Inc. was selected after presenting an innovative project that will adopt advanced genomic tools in their breeding program. The company will receive a comprehensive cannabis genomic starter…

Details

NIC Reports First Quarter 2020 Results

April 27, 2020

OLATHE, Kan.–(BUSINESS WIRE)–NIC Inc. (Nasdaq: EGOV), the leading provider of digital government services, announced results for the first quarter of 2020 that ended March 31, 2020, as compared to the first quarter of 2019. Total revenues of $91.1 million, a 7% increase. Operating income of $15.3 million, a 2% increase. Net income of $11.9 million,…

Details

LOKELMA US Label Updated to Include Dosing Guidance for the Treatment of Hyperkalemia in Patients With End-Stage Renal Disease on Hemodialysis

April 27, 2020

WILMINGTON, Del.–(BUSINESS WIRE)–Today, the US Food and Drug Administration (FDA) approved a label update in the US for AstraZeneca’s LOKELMA® (sodium zirconium cyclosilicate) to include a dosing regimen specifically to treat hyperkalemia in patients with end-stage renal disease on chronic hemodialysis. The approval by the US FDA was based on positive results from the Phase…

Details